DeciBio
David Cavanaugh is the Vice President at DeciBio, where David joined in April 2012 to build out the strategy consulting service offering. David supports all consulting aspects from lead generation to project management, with recent projects including market entry strategies and product assessments. David also leads internal firm operations and has previous experience as a Director on the Board of Directors at Reaching Out MBA, Inc, and as a Senior Manager at L.E.K. Consulting. With a background in bioinformatics and bioinformatician roles at Genentech, GSK, and Thomas Jefferson University, David holds an MBA in Health Industry Management, Biotechnology, and International Business Strategy from Northwestern University.
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.